This database contains information about more than 6,000 publications on autism and related issues.
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.
Please use the Search Function to find specific items.
This page shows the results of your search for publications containing the term "Haloperidol". See definition (new window)
Malone R. P. et al. (1991)
Repeated episodes of neuroleptic-related dyskinesias in autistic children.
Psychopharmacology Bulletin
27(2), pp. 113-117
Pharmacotherapy of pervasive developmental disorders in children and adolescents.
CNS Drugs
18(14), pp. 1031-1052
European Child and Adolescent Psychiatry
17(1), pp. 1-8.
Mohiuddin S. , Ghaziuddin M. (2013)
Psychopharmacology of autism spectrum disorders: A selective review.
Autism
17(6), pp. 645-654.
Should autistic children be treated with haloperidol?
American Journal of Psychiatry
142(7), pp. 883-884
Journal of the American Academy of Child and Adolescent Psychiatry
28 pp. 87-92
American Society of Health-System Pharmacists (2008)
Bethesda, MD: American Society of Health-System Pharmacists
Posey D. J. et al. (2008)
Antipsychotics in the treatment of autism.
Journal of Clinical Investigation
118(1), pp. 6-14
Posey D. J. , McDougle C. J. (2001)
Pharmacotherapeutic management of autism.
Expert Opinion on Pharmacotherapy
2(4), pp. 587-600
Rajapakse T. , Pringsheim T. (2010)
Pharmacotherapeutics of tourette syndrome and stereotypies in autism.
Seminars in Pediatric Neurology
17(4), pp. 254-260
Sanchez L. e. et al. (1995)
A comparison of live and videotape ratings: clomipramine and haloperidol in autism.
Psychopharmacology Bulletin
31(2), pp. 371-378.
Silva R. R. et al. (1993)
Haloperidol withdrawal and weight changes in autistic children.
Psychopharmacology Bulletin
29(2), pp. 287-291
What's in the pipeline? Drugs in development for autism spectrum disorder.
Neuropsychiatric Disease and Treatment
(10), pp. 371-381.
Lancet
371(9606), pp. 57-63.
Journal of Behavior Therapy and Experimental Psychiatry
22(4), pp. 299-304